Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.3 to v3.5.0 to reflect the current site version. No content or core functionality was changed.
    Difference
    0.0%
    Check dated 2026-03-18T20:17:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a backend or formatting update and does not modify study content or functionality visible to users.
    Difference
    0.0%
    Check dated 2026-03-11T17:25:22.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, and the funding-status notice along with the previous Revision: v3.4.1 note has been removed; this is a site-wide messaging update that does not alter the study content.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:16.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added a global notice about a lapse in government funding with status update that the NIH Clinical Center is open, and updated the site version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:20:34.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Added a Show glossary feature and updated study record metadata to display 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels used 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-28T06:09:55.000Z thumbnail image
  8. Check
    71 days ago
    Change Detected
    Summary
    Updated the page revision from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T02:21:10.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.